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OVERVIEW — The Medicare drug benefit (Medicare "Part 
D"), provides federal subsidies to pay premiums and cost 
sharing for low-income beneficiaries—almost 10 million in 
2009. Yet there are several policy issues concerning these 
low-income beneficiaries under Part D. First, over 2 mil-
lion individuals who may qualify for the subsidies have not 
enrolled. Second, in some states, low-income beneficiaries 
have little choice of plans (while non low-income beneficia-
ries have dozens of choices), unless they pay out-of-pocket 
for premium amounts above what the subsidy covers. And 
third, millions of those who have enrolled in the benefit face 
the prospect each year of switching drug plans or paying 
more to keep their current drug plan. What led to this state 
of affairs? Are there lessons to be learned from Medicare 
Part D as Congress debates how to provide health insurance 
subsidies on behalf of low-income individuals?
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The Medicare Prescription Drug, Improvement, and Mod-ernization Act of 2003 (MMA) established a voluntary 
outpatient prescription drug benefit (“Part D”), for Medicare 
beneficiaries. The Medicare drug benefit began January 1, 
2006, and is administered through private prescription drug 
plans (PDPs) for beneficiaries in fee-for-service Medicare1 
and through Medicare Advantage drug plans (MA-PDs) for 
beneficiaries enrolled in Medicare managed care plans. The 
private drug plans compete for enrollment based on the pre-
miums, benefit package (including a formulary, that is, the 
list of drugs it covers), cost-sharing, pharmacy network and 
other drug plan attributes. Organizations intending to offer 
a Medicare drug benefit submit bids to the Centers for Medi-
care & Medicaid Services (CMS), and beneficiary premiums 
are derived from the bids.2 The lower a plan’s bid, the low-
er its beneficiary premium. Beneficiaries dually eligible for 
both Medicare and Medicaid and many other low-income 
beneficiaries may enroll in a drug plan without having to 
pay a monthly premium if they select a basic benefit plan 
with a premium that is at or below an amount called the 
low-income benchmark premium (an average premium, de-
scribed in more detail later in this paper). 
Several issues related to low-income individuals under Part D con-
cern policymakers. First, an estimated 2 million low-income ben-
eficiaries who may be eligible for federal subsidies of their drug 
coverage are not enrolled. It is not known if these beneficiaries are 
foregoing federally subsidized drug coverage purposefully or due to 
a lack of awareness.
Second, there is considerable geographic variation in the number 
of PDPs being offered premium-free to low-income beneficiaries; in 
2009, there is only 1 plan in Nevada but 16 plan choices in Wisconsin. 
Beneficiaries may also select an MA-PD, but those preferring to stay 
in fee-for-service Medicare have few choices in some states.
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Third, the plans that are offered premium-free have changed from 
one year to the next. As the plans offered premium-free to low-in-
come beneficiaries change, millions of low-income beneficiaries are 
faced with switching drug plans or paying the difference between 
their plan’s premium and the low-income benchmark premium. 
About 23 percent of low income beneficiaries enrolled in Part D—2.2 
million people—faced with this dilemma in 2009 alone.3 
Some beneficiaries not qualifying for extra assistance, many of whom 
are also living on limited means, make difficult choices in the face of 
health care cost increases. However, the lowest income beneficiaries 
are least able to pay additional premium amounts or adapt easily to 
the formulary and procedures of new prescription drug plans. 
DRUg BEnEFIT BaSIcS 
Over 45.24 million Medicare beneficiaries are eligible for Medicare Part 
D, including low-income and non low-income beneficiaries. Of those, 
nearly 41 million—over 90 percent—have prescription drug coverage 
through sources including “stand-alone” PDPs or MA-PDs, a former 
employer receiving a Medicare retiree 
drug subsidy,4 or other sources such as 
the Veterans Administration, a current 
employer, a Medicare supplemental (or 
Medigap) policy, or the Indian Health 
Service. About 4.46 million beneficiaries, 
including roughly 2 million low-income 
individuals, have no known source of 
drug coverage. (See Figure 1, right.)
The vast majority of Medicare benefi-
ciaries are enrolled in PDPs and MA-
PDs—17.48 million and 9.17 million, 
respectively, in 2009. Those beneficia-
ries can choose among dozens of plan 
options available in each of 34 regions 
across the country. While the number 
of options varies from region to region, 
most beneficiaries can choose from of 
about 50 PDPs and dozens of MA-PDs. 
Beneficiaries enrolling in a drug plan 
pay monthly premiums, in addition to 
*  Other coverage includes: TRICARE, FEHBP, VA, active workers with Medicare secondary 
payer, retirees in plans not receiving the retiree drug subsidy, Medigap, Indian Health Service, 
and state pharmaceutical assistance programs.
Source: Centers for Medicare & Medicaid Services, 2009 Enrollment Information, Total 
Medicare Beneficiaries with Prescription Drug Coverage, as of February 1, 2009, available at 
www.cms.hhs.gov/PrescriptionDrugcovGenIn.
FigurE 1
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cost sharing and any deductible.5 The standard benefit package in 2009 
consists of a $295 yearly deductible, 25 percent coinsurance for drug 
spending between $295 and $2,700, and 100 percent coinsurance after 
the beneficiary reaches $2,700 until $4,350 is spent out of pocket (a gap 
in coverage popularly known as the “donut hole”). After a beneficiary 
spends $4,350 out of pocket, catastrophic coverage begins which reduc-
es cost sharing to a minimal amount. Most beneficiaries are enrolled in 
plans that have an alternative benefit package that has the same benefit 
value (that is, it is actuarially equivalent) to the standard benefit. 
Medicare subsidizes the cost of the drug benefit for all enrollees, pay-
ing 74.5 percent of program costs. Federal expenditures for Medicare 
Part D are expected to total almost $63 billion in 2009.6 Medicare 
makes additional payments to drug plans to subsidize the premiums, 
cost sharing, and deductibles of beneficiaries with limited income 
and assets. This is known as the low-income subsidy (LIS). In 2009, 
drug plans are expected to be paid an average of $1,105 per enrollee 
for drug benefits and another $1,950 per low-income enrollee to subsi-
dize the additional benefits available to them.7 About one-third of to-
tal Medicare outlays for Part D are for these additional LIS payments. 
Of the 26.65 million beneficiaries enrolled in PDPs and MA-PDs in 
2009, over one-third (9.67 million) are enrolled in the LIS program.8 
lOW-IncOME BEnEFIcIaRIES In PaRT D
An estimated 12.5 million beneficiaries are eligible for extra benefits 
under Part D including payment of drug plan premiums, co-pays and 
deductibles. However, only 9.67 million of those potentially eligible 
for Part D and the extra benefits are enrolled in 2009, despite federal 
and local efforts to increase awareness of the benefit and enroll them.
Eligibilit y and Benefit s 
The LIS program significantly reduces out-of-pocket costs, includ-
ing no or lower beneficiary premiums and limited cost-sharing (Fig-
ure 2, next page). Unlike non low-income beneficiaries, beneficiaries 
qualifying for the LIS continue to have their prescription drugs paid 
for through the donut hole. 
Beneficiaries become eligible for the LIS when their incomes are at or 
below 150 percent of the federal poverty level ($16,245 for an individual 
and $21,855 for a couple in 2009) and they have limited assets ($11,010 
www.nhpf.org
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for an individual and $22,010 for a couple in 2009).9 The amount of as-
sistance varies, depending on the income and assets of the beneficiary. 
In other words, lower income beneficiaries receive the most assistance, 
an estimated 12.5 million medicare beneficiaries have annual incomes 
of less than 150 percent of the federal poverty level ($16,245 for an 
individual; $21,855 for a couple) and meet certain asset requirements, 
making them eligible for financial help with their Part D premiums, 
deductibles, and copays. the amount of assistance available depends 
on the income and asset levels of the beneficiary.
FigurE 2 
The Low-income Subsidy: 
Extra Assistance in 2009 
for Beneficiaries with 
Limited Means
Premium Subsidies Taper Off for 
Dual Eligibles with Larger incomes
For beneficiaries with incomes at or above 
135% FPl and with assets valued above $11,010 
(for an individual, or $22,010 for a couple), the 
amount of premium subsidy decreases. Ben-
eficiaries with incomes at or above 150% FPl 








Sliding Scale: Partial Premium Subsidies
Percent of Federal Poverty Level
140% 150%135% 145%
§ Copayment and deductible amounts are indexed in future years. 
¶ The catastrophic limit is defined as the point at which an individual has 
spent $4,350 out of pocket on covered drugs in 2009. 
Sources: CMS-4068-F, Federal Register, January 28, 2005, pp. 4388–4389; 
and CMS Announcement, April 6, 2009, available at www.cms.hhs.gov/
medicareadvtgSpecrateStats/Downloads/announcement2010.pdf.
* Individuals who are not living in an institution. Institutionalized 
dual eligibles are exempt from all cost sharing.
† Asset tests vary by state for full-benefit dual eligibles.
‡ No premium is required if the individual selects a PDP with a 
premium less than or equal to the low-income benchmark. 
 Assets
 BEnEFIcIaRy gROUPS
 Full Benefit Dual Eligibles* Non-Full Benefit Dual Eligibles
 income <100% FPL >100% FPL  <135% FPL  >135% to 150% FPL
 Individual N/A† N/A† $6,600 >$6,600 but <$11,010 <$11,010 
 couple   $9,910 >$9,910 but <$22,010 <$22,010 
 Premium Subsidy (%) 100%‡ 100%‡ 100%‡ 100%‡ Partial (see “Sliding Scale”)
 Deductible None None None $60 $60
 Copay (generic/brand)§ $1.10/$3.20  $2.40/$6.00 $2.40/$6.00 15% coinsurance 15% coinsurance
  Above Catastrophic No cost No cost No cost $2.40/$6.00 copay $2.40/$6.00 copay  Limit?¶ sharing sharing sharing
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including payment of the monthly drug plan premium if they enroll 
in an eligible plan. 
As Figure 2 shows, beneficiaries with incomes below 135 percent of 
the federal poverty level and few assets generally pay no monthly 
drug premium, most pay no deductible, and all have lower cost shar-
ing amounts than non low-income beneficiaries. Beneficiaries with 
incomes at or above 135 percent of FPL but below 150 percent of FPL 
pay premiums on a sliding scale according to income, and have lower 
deductibles and coinsurance than beneficiaries not receiving the LIS. 
Enrollment and auto -enrollment 
Some low-income beneficiaries automatically qualify for LIS, where-
as others must apply for it. Groups of beneficiaries automatically 
qualifying for LIS include: beneficiaries eligible for both Medicare 
and Medicaid (“dual eligibles”), beneficiaries who receive supple-
mental security income (SSI) but are not dually eligible, and ben-
eficiaries enrolled in Medicare Savings Programs (federal-state pro-
grams that help low-income beneficiaries pay Medicare premiums, 
deductibles, and copayments). Beneficiaries who do not fall into one 
of these three groups but believe they meet the income and asset 
requirements may apply for LIS benefits, either through a state office 
or the Social Security Administration (SSA).
LIS beneficiaries receive assistance with enrollment in a drug plan. 
Those who automatically qualify for the LIS but do not choose a 
prescription drug plan on their own are automatically enrolled, or 
“auto-enrolled,” in one by Medicare when they first qualify for LIS. 
Beneficiaries who apply for and receive LIS, but then fail to select a 
plan, are also enrolled by Medicare (often referred to as “facilitated 
enrollment”). When a beneficiary does not choose a plan on his own, 
he is randomly assigned to a drug plan with a basic benefit package 
that has a premium at or below the low-income benchmark premi-
um. Low-income beneficiaries, including those randomly assigned 
to a plan, are free to change plans during the year, whereas ben-
eficiaries not receiving LIS may only change plans during an open 
enrollment period in late fall. 
Auto-enrollment helps ensure that as many known low-income ben-
eficiaries as possible are enrolled in a drug plan. However, there is no 
guarantee that the plan to which a beneficiary is randomly assigned 
www.nhpf.org
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has a formulary that includes the drugs the beneficiary is taking. 
For this reason, some have suggested that plan assignment take into 
account what drugs a beneficiary is taking and other factors unique 
to an individual beneficiary.10 Conversely, so-called “beneficiary-
centered assignment” could increase the number of beneficiaries 
changing plans each year as beneficiaries are moved into plans that 
better meet their needs. And, plan costs could increase as more ben-
eficiaries are auto-enrolled into plans because their formulary in-
cludes the needed drugs. These unintended consequences would 
need to be thought through before a policy change is made.
As Table 1 indicates, many beneficiaries—an estimated 2.34 million in 
2009—may be eligible for low-income assistance but are not enrolled. 
There are many reasons why such a large share of eligible individuals 
would not enroll in Part D or fail to enroll in the LIS; factors that may 
play a role include lack of awareness, perceived lack of need (particu-
larly for beneficiaries with no drug spend-
ing), language barriers, mental illness, low 
literacy, other coverage not known to Medi-
care, and personal preference. Beneficiaries 
may also experience a change in circum-
stances that qualifies them for LIS, such 
as loss of a spouse, or change in income or 
assets, but fail to connect the change to po-
tential eligibility. 
CMS (the agency that oversees Medicare), 
SSA, and numerous advocacy organiza-
tions have undertaken efforts to reach out 
to and enroll beneficiaries potentially eli-
gible for LIS. SSA, for example, sends letters 
to beneficiaries who the agency believes 
may be eligible for LIS based on the amount 
of their Social Security benefit. CMS has 
worked with beneficiary groups to identify 
and implement best practices for locating 
and enrolling potentially eligible beneficia-
ries, particularly those with limited English 
proficiency and low literacy. CMS has been 
trying multiple approaches to targeting 
potentially eligible individuals, including 
identifying and focusing outreach efforts 
 LiS-Eligible Beneficiaries (millions) 
2006 2007   2008* 2009*
Estimated Total LiS-
Eligible Beneficiaries 13.20 13.20 12.50 12.50
total Drug coverage 
from medicare** 9.0 9.18 9.42 9.67
other Sources of 
creditable coverage 
(Va, IHS, SPaPs)
1.0 0.72 0.42 0.42
anticipated Facilitated 
enrollments   N / a 0.03 0.06 0.01
Potentially eligible 
but Not enrolled 3.2 3.27 2.60 2.34
 * Starting in 2008, CMS changed the method of estimating the number of low-income 
eligible beneficiaries, lowering the estimate from 13.20 in 2006 and 2007 to 12.5 million 
in 2008 and 2009. (Table numbers here may not total 12.5 million due to rounding.)
 ** Includes enrollment in PDPs and MA-PDs. For 2008 and 2009 includes beneficiaries 
who qualify for LIS but for whom their employer received a retiree drug subsidy on 
their behalf (approximately 40,000 in 2008 and 30,000 in 2009).
Source: Centers for Medicare & Medicaid Services, 2009 Enrollment Information, LIS-
Eligible Medicare Beneficiaries with Drug Coverage, available at www.cms.hhs.gov/
PrescriptionDrugcovGenIn.
TABLE 1: Medicare Beneficiaries Eligible for  
Low-income Subsidy (by Source of coverage), 2006–2009
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on ZIP codes that have high numbers of beneficiaries who are poten-
tially eligible for the LIS, but not enrolled.11 
CMS has also conducted focus groups, telephone interviews and oth-
er qualitative research in an effort to better understand reasons why 
low-income beneficiaries have not enrolled in Part D. For example, 
CMS research indicates that urban beneficiaries prefer to learn about 
LIS directly from Medicare or the SSA, rather than local beneficiary 
groups that seem to be a trusted information source for other benefi-
ciaries. Rural beneficiaries who have not enrolled seem to be wary of 
how Par t D Works for low- Income Residents of  
U.S .  Territories and Indian Reservations
While many of the features of Medicare Part D are the same for non low-income beneficiaries 
who reside in the territories or receive their health care from Indian Health Service facilities, 
there are a few important differences.
residents of u.S. territories — Over 650,000 
Medicare beneficiaries reside in the U.S. ter-
ritories (including Puerto Rico, the U.S. Vir-
gin Islands, Guam, American Samoa and 
Northern Mariana Islands).* Much of the de-
sign of Medicare Part D is the same in the 
territories as it is on the U.S. mainland. Plan 
design (including cost sharing and deduct-
ibles), bidding, and plan contracting are all 
similar. However, low-income beneficiaries 
residing in the territories are not eligible for 
the LIS. Instead, the territories receive a grant 
of federal Medicaid funds to permit each ter-
ritory’s Medicaid program to “wrap around” 
Medicare drug coverage for beneficiaries du-
ally eligible for both Medicare and Medicaid. 
This wrap-around benefit is only available 
to full dual eligible beneficiaries. Non–dual 
eligible beneficiaries under 150 percent of the 
federal poverty line—who would be eligible 
for assistance with premiums and cost shar-
ing if they resided in the U.S. mainland—
are not eligible for the extra benefits which 
are funded with Medicaid dollars, and the 
non-duals are not Medicaid recipients. 
Indian Health Service — While Medicare Part 
D works the same for American Indians 
and Alaska natives as for any beneficiary, 
some do not enroll in Part D or the LIS. 
Most American Indians and Alaska Na-
tives receive health care services free of 
charge at Indian Health Service (IHS) fa-
cilities, including prescription drugs. From 
the beneficiary perspective, there is little 
need to enroll in Part D because prescrip-
tion drugs are already free. However, the 
IHS encourages beneficiaries to enroll in 
Part D, particularly if they may qualify for 
the LIS, so that Medicare is the primary 
payer for these Medicare beneficiaries. 
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providing personal information to anyone, have a strong sense of in-
dependence that might hinder enrollment in a public program, and 
are less likely than urban beneficiaries to contact Medicare or SSA 
for information about federal programs.12 CMS is using this type of 
feedback to target the method, means, and type of communication it 
has with potentially eligible beneficiaries. Despite targeted interven-
tions, however, many beneficiaries, including low-income beneficia-
ries, remain unenrolled. 
The failure of low-income persons to enroll in available subsidy 
programs is not unique to Medicare Part D. While it is difficult to 
estimate the number of potentially eligible individuals for any pro-
gram, some analysts believe that millions of Americans are eligible 
for, but not enrolled in, other federally subsidized health insurance 
programs including Medicaid, the Children’s Health Insurance Pro-
gram, and Medicare Savings Programs.13
VaRIaTIOn In DRUg Pl an aVaIl aBIlIT y
Low-income beneficiaries make up a sizeable share of enrollment in 
PDPs and MA-PDs. About 45 percent of the beneficiaries enrolled 
in PDPs and about 17 percent of beneficiaries enrolled in MA-PDs 
receive the LIS.14 However, not all individual drug plans have a large 
share of low-income beneficiaries. Because Medicare only pays the 
full premium of basic benefit package drug plans that have premi-
ums at or below the average in a geographic area, the great majority 
of LIS beneficiaries are in below-average cost plans.15 The average 
beneficiary premium in an area, weighted by enrollment of LIS ben-
eficiaries, is called the low-income benchmark premium.16 If a low-
income beneficiary selects a plan with a premium above the low-
income benchmark premium, the beneficiary pays the difference.17 
Beneficiaries are not auto-enrolled into plans with premiums above 
the benchmark. Drug plan premiums change each year; therefore, 
a plan with a premium below the benchmark this year may have 
a premium above the benchmark next year. If this happens, low- 
income beneficiaries then must decide between staying in the same 
plan—and paying the difference between the plan’s premium and 
benchmark premium—or enrolling in another plan with a premium 
below the benchmark. In 2009, about 2 million LIS beneficiaries are 
enrolled in non-benchmark plans and are paying Part D premiums.18 
Once a beneficiary chooses a plan on his or her own, CMS will not 
July 31, 2009 NatIoNal HealtH PolIcy Forum 
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reassign the beneficiary to another 
plan, even if the beneficiary’s plan 
has a premium above the bench-
mark in a future year.
The policy rationale for Medicare 
paying the full premiums only for 
basic benefit plans with premiums 
below the low-income benchmark 
is to ensure that Medicare is not 
paying for the most costly plans, 
and to encourage plans to bid as 
low as possible in order to attract 
enrollment. If Medicare paid the 
full premium of plans with higher-
than-average premiums, program 
costs would be higher, and plans 
would have less incentive to bid 
competitively. 
The number of plans with premi-
ums under the benchmark (and 
therefore available to most low-
income beneficiaries at zero pre-
mium) and the variation in the 
number available from region to 
region are policy concerns. The 
number of drug plans with pre-
miums below the benchmark 
generally increased between 2006 
and 2007; since then, however, the 
number of such plans generally 
declined—with steep declines in 
some regions. Indeed, all regions 
except Wisconsin experienced a 
decline in the number of plans 
with premiums under the bench-
mark in 2009.19 Figure 3 highlights 
notable patterns in the availability 
of plans with premiums below the 
benchmark. The 2006–2009 experi-
ence of Region 1 (New Hampshire 
A few regions, including 
Texas, have observed only 





















Region 1 has followed a typical pattern: 
an increase in below-benchmark plans 
from 2006 to 2007, but then a decline in 
the number of plans for 2008 and 2009.
Nevada and Arizona have had a 
relatively small number of plans 
below the benchmark since the 
start of the drug benefit in 2006. 
For 2009, Nevada has 1 plan and 
Arizona has two plans below the 
benchmark.  
Number of Below-Benchmark 
Plans, Nationwide
Sources: Centers for Medicare & Medic-
aid Services, 2009 Landscape Source and 
2008 Landscape Source, www.cms.hhs.gov/
PrescriptionDrugcovGenIn. 2007 and 2006 
Landscape Source files no longer available 
online; accessed April 2009. And "Medicare 
Part D, Prescription Drug Plan (PDP) Avail-
ability in 2009," Kaiser Family Foundation, 
November 2008, available at www.kff.org/
medicare/upload/7426_05.pdf.
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and Maine) is typical: an increase in plans for 2007 followed by rather 
steep declines in 2008 and 2009. (See also Appendix 1 for 2006–2009 
regional low-income benchmark premiums and the number of plans 
with premiums below the benchmark).
From a policy perspective, it is not clear what the “right” number of 
plans with premiums below the benchmark should be. While some 
might argue that many low-income beneficiaries would have difficul-
ty comparing coverage among many plans and making a choice, oth-
ers believe that choice should be as broad as possible. Some analysts 
and advocates believe that providing plan choice allows individuals 
the opportunity to select a plan whose formulary and other features 
best meet their needs while encouraging plan innovation. Others 
note that prior to implementation of Part D in 2006, most low-income 
beneficiaries received their drug coverage through Medicaid—with 
no choice of plans at all. In addition, states with the lowest numbers 
of below-the-benchmark plans also have a high percentage of low- 
income beneficiaries in Medicare managed care plans, so having 
more choices of PDPs is less important. In any event, there is some 
degree of discomfort among policymakers with the significant varia-
tion in the number of available zero-premium plans from one region 
to another, as well as the discrepancy between the amount of choice 
available to these beneficiaries compared to other beneficiaries.
DRUg Pl an aVaIl aBIlIT y OVER TIME
A second major policy issue related to the bidding and benchmarks 
is that, because benchmark is calculated annually, each year the mix 
of plans with premiums at or below the benchmark has changed. Ac-
cording to CMS, 2.2 million beneficiaries—about 23 percent of low-
income beneficiaries enrolled in PDPs and MA-PDs—were either 
switched or were notified that they needed to switch to avoid paying 
a premium (or an increased premium) for 2009. For 2008, 2.6 million 
low-income beneficiaries were affected by these changes. Further, 
recent analysis indicates that, of the 409 plans with premiums be-
low the benchmark the first year of the drug benefit (2006), only 96 
of them—23 percent—had premiums below the benchmark in 2007, 
2008 and 2009.20 Some beneficiaries have been enrolled in two, three, 
or more plans since the start of the program in 2006.
The number of beneficiaries switching plans is troubling from a policy 
perspective for several reasons. First, it is confusing for beneficiaries. 
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This population tends to have higher drug utilization, more chronic 
health conditions (including mental health conditions), and cogni-
tive impairments than the average American, all of which can make 
frequent changes in drug plans more difficult. Understanding which 
drugs are on plan formularies, which pharmacies are preferred, how 
to manage an appeal or grievance, and how to contact the plan is par-
ticularly challenging for many in this population. 
Second, beneficiaries may be subject to utilization management tech-
niques (prior authorization or step therapy, for example) in one plan, 
and be subject to different techniques in another plan the following 
year. While utilization management techniques are widely used and 
accepted tools, annual changes in the techniques and the drug sub-
stitutions may not be desirable, especially for this population. CMS 
has requirements for short-term supplies of a drug during a transi-
tion period, but staying on a preferred drug long-term sometimes 
requires effort by both the physician and the beneficiary. It is not yet 
clear whether changing plans leads to widespread quality-of-care 
issues, such as medication reactions because of therapeutic substitu-
tion or a confused beneficiary not refilling a prescription on time. 
Third, the percentage of individuals switching plans is much higher 
among low-income beneficiaries than in the non low-income popu-
lation: only about 6 percent of non low-income beneficiaries change 
Medicare drug plans in a given year. The experience of non low-in-
come beneficiaries under Part D is consistent with that of of enrollees 
in the Federal Employees Health Benefits Program—about 6 percent 
of federal employees nationwide switch health insurance plans in any 
given year.21 Non low-income individuals most often elect to stay in 
their current plan, even if it costs more. It is worth noting that many 
Medicare beneficiaries are faced with difficult choices and trade-offs in 
spending each year, particularly when it comes to health care spend-
ing, and deciding whether to switch prescription drug plans because 
of cost is only one such decision. However, some may feel that the 
prospect of switching plans is a “price to pay” for the federal subsidy. 
Fourth, there may be some modest hidden costs involved in switch-
ing plans. Plans incur costs educating new beneficiaries through 
printed material and fielding beneficiary phone calls about new for-
mularies and plan requirements. Pharmacy costs include counsel-
ing beneficiaries regarding formulary changes at the point of sale 
and updating computer systems with new plan information. Physi-
cian offices may find that annual drug plan changes result in more 
www.nhpf.org
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of their time being spent on pharmacy issues as they handle plan 
requests for medication changes. For some patients, drug switches 
require an office visit, perhaps adding to Part B costs.
a clOSER lOOk BEhInD  
annUal changES In Pl an OPTIOnS 
It is instructive to understand why plan options change for low- 
income beneficiaries from year to year. The low-income benchmark 
premium amount is key to this. It determines how many plans, and 
which particular plans, are offered to low-income beneficiaries pre-
mium-free. The multi-year example in Appendix 2 illustrates how the 
low-income benchmark is calculated, and how the number and mix 
of plans with premiums below the benchmark change annually.22 
Several issues contribute to the fluctuation of the premium and the 
policy concerns described above that accompany it. These mostly 
technical issues are worth considering as policymakers weigh op-
tions to reduce the number of low-income beneficiaries experiencing 
a disruption of prescription drug coverage. 
Payment adequacy and risk adjustment.•   Payments to drug plans 
are adjusted to reflect certain characteristics of all beneficiaries 
including age, gender, and health status. Payments to plans on 
behalf of low-income beneficiaries are further adjusted to reflect 
the fact that low-income beneficiaries use more prescription 
drugs than other beneficiaries. Some researchers and plans be-
lieve that the adjustments to plan payments may not be adequate 
to account for these higher costs.23 If payments to a plan for low-
income beneficiaries do not accurately reflect the plan’s actual 
costs in one year, then the plan may not bid as competitively 
as possible in a future year to avoid the risk of covering low- 
income beneficiaries. In the Part D bidding process, plans must 
bid based on expected expenses and utilization, and plans must 
not bid based solely on a strategy of including or excluding cer-
tain groups. However, there is some judgment in putting the 
many pieces of bid information together to ensure that expenses 
are covered. If plans feel that the payment is inadequate to ac-
count for the costs of low-income beneficiaries, then their bid 
may reflect that belief. If the plan’s bid places its premium above 
the benchmark, then beneficiaries would need to decide whether 
to stay in the plan or enroll in a new plan below the benchmark. 
If many below-benchmark plans conduct themselves in this 
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manner, the result can be instability in plan choices for benefi-
ciaries and perhaps higher premiums over time.
Calculation of the low-income benchmark premium.•   Although 
highly technical, the manner in which the low-income benchmark 
premium is calculated is very important because even seemingly 
modest changes may result in more plans or fewer plans having 
premiums below the benchmark. For the first several years of the 
drug benefit, the low-income benchmark premium was calculated 
in a manner that some analysts believe kept the benchmark pre-
mium artificially high. CMS changed the calculation for 2009 and 
future years. The calculation now involves multiplying the plan’s 
premium by the percentage of LIS beneficiaries enrolled in the 
plan.24 The policy rationale for this change was to better reflect the 
premiums of plans that actually enroll LIS beneficiaries, and to re-
duce the effect of MA-PD premiums in the calculation (see below). 
The overall result is intended to be a reduction in the number of 
beneficiaries switching plans. It is not yet clear what the result 
over time will be. However, some analysts are concerned that the 
benchmark will actually be depressed over time.
inclusion of MA premiums in the calculation of the benchmark. •  The 
drug portion of the MA premium is included in the benchmark 
calculation, consistent with the statute. The inclusion of MA pre-
miums depresses the benchmark because the MA-PD premium 
amounts used in the calculation are lower on average than the 
premiums of free-standing drug plans. The MA-PD premiums are 
considered artificially low for purposes of the calculation because 
MA-PDs are permitted to apply money saved providing benefits 
under Parts A and B (known as rebates) to the premium amounts. 
If MA plans were excluded from the benchmark, or if the premi-
um amount did not include rebate dollars, the low-income bench-
mark premium likely would increase, and more plans would have 
premiums below the benchmark. 
cOnclUSIOn
Reliance on competitive bidding to determine premiums and over-
all program costs is a hallmark of Medicare Part D. But the nature 
of the bidding process has introduced instability in the number of 
plans and the particular plans offered to low-income beneficiaries. 
Consquently, low-income beneficiaries might not remain in a pre-
scription drug plan over the long term. This fluctuation may lead 
to beneficiary confusion around plan choices and enrollment. It is 
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not clear whether or not frequent plan changes result in quality-of-
care issues, but that would be of great concern. And the instability 
may prove costly both for pharmacies dealing with beneficiaries at 
the point of sale and for physicians and their staffs who field phone 
calls from pharmacies regarding medication changes at the request 
of drug plans. 
Congress is considering health reform legislation that would in-
volve providing subsidies for the purchase of health insurance on an 
income-related basis. Medicare’s Part D experience to date may be 
instructive as proposals are refined. Providing the highest subsidy 
level only to plans with average or below premiums has been a suc-
cessful tool for keeping federal costs as low as possible. However, 
there has been disruption in plan enrollment and choice for low-
income beneficiaries. Policymakers may want to consider the experi-
ence of low-income beneficiaries under Part D as they debate health 
reform measures. 
EnDnOTES
 Beneficiaries enrolled in one type of Medicare managed care plan, called a 1. 
private fee-for-service plan, may also enroll in a PDP because the private fee-for-
service plan is not required to offer a prescription drug benefit.
 For a discussion of how the bid is converted into a monthly beneficiary pre-2. 
mium, please see Medicare Payment Advisory Commission (MedPAC), “Part D 
Payment System,” paymentbasics, revised October 2008; available at www.medpac.gov/
documents/medPac_Payment_Basics_08_PartD.pdf.
 Some beneficiaries switch to a lower-premium drug plan offered by the same 3. 
company or sponsor which may have the same formulary. 
 Employers offering a qualified drug benefit to Medicare-eligible retirees are 4. 
eligible to receive a subsidy from Medicare known as the retiree drug subsidy to 
defray the cost of providing a drug benefit. In 2009, Medicare will pay roughly 
$600 per beneficiary enrolled in such plans. See 2009 Annual Report of the Boards of 
Trustees of the Federal Hospital Insurance and Federal Supplementary Medicare Insurance 
Trust Funds, May 12, 2009, p.163; available at www.cms.hhs.gov/reportstrustFunds/ 
downloads/tr2009.pdf. 
 For more background information on the Medicare drug benefit please see 5. 
“The Medicare Drug Benefit (Part D),” National Health Policy Forum, The Basics, 
January 15, 2009, available at www.nhpf.org/library/details.cfm/2708, and background 
and presentation material from the fundamentals briefing, “Understanding Medi-
care and Medicaid: Fundamentals and Issues for the New Congress,” January 15, 
2009, available at www.nhpf.org/briefbook09tab5.cfm.
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 6. 2009 Trustees Report, p. 120. Amount includes federal expenditures for the re-
tiree drug subsidy.
 7. 2009 Trustees Report, p. 163. 
 Nearly one-half million additional low-income beneficiaries have drug cover-8. 
age from sources other than Medicare, such as the Veterans Administration (VA), 
Indian Health Service (IHS), and state pharmaceutical assistance programs (SPAPs).
 For all states, except Alaska, Hawaii, and DC, where separate guidelines apply. 9. 
Centers for Medicare & Medicaid Services (CMS), “Guidance to States on the Low-In-
come Subsidy,” February 2009; available at www.cms.hhs.gov/lowIncSubmedicarePrescov/
Downloads/StatelISGuidance021009.pdf.
  See “The Role of Beneficiary-Centered Assignment for Medicare Part D,” a 10. 
study conducted by Georgetown University and NORC at the University of Chi-
cago for MedPAC, June 2007, available at www.medpac.gov/documents/June07_Bene_
centered_assignment_contractor.pdf. Also see “Beneficiary-Centered Assignment and 
Medicare Part D,” presentation to MedPAC by Jack Hoadley et al., September 4, 
2008, available at www.medpac.gov/transcripts/Hoadley%20medPac%20presentation%20
09%2004%2008.pdf.
 See, for example, CMS, “LIS Outreach Toolkit Numeric Maps,” April 2009; 11. 
available at www.cms.hhs.gov/Partnerships/99_lIS_outreach_toolkit_Numeric_maps.
asp#topofPage.
 CMS, “Formative Research on the Low Income Not Enrolled Population“; avail-12. 
able at www.cms.hhs.gov/Partnerships/Downloads/low_Income_Initial_Qualitative_research.pdf.
 See, for example, “Secretary Sebelius Announces Availability of $40 Mil-13. 
lion in Grants to Help Insure More Children,” U.S. Department of Health and 
Human Services, press release, July 6, 2009; available at www.hhs.gov/news/
press/2009pres/07/20090706a.html.
 MedPAC, 14. Report to the Congress: Medicare Payment Policy, March 2009, p. 283; 
available at www.medpac.gov/documents/mar09_entirereport.pdf.
 There are 34 regions nationwide. Many regions encompass only one state, and 15. 
a few are multi-state.
 The premium of a plan with very high LIS (low-income subsidy) enrollment 16. 
counts more in calculating the average than a plan with lower enrollment.
 For 2007 and 2008, CMS permitted plans with premiums slightly above the 17. 
benchmark (a so-called de minimus amount above the benchmark)—$2 in 2007 and 
$1 in 2008—to offer the plan at zero premium. The policy was discontinued begin-
ning in 2009.
 “Medicare Prescription Drug Plans in 2009 and Key Changes Since 2006: Key 18. 
Findings,” Elizabeth Hargrave et al. for Kaiser Family Foundation, June 2009; 
available at www.kff.org/medicare/upload/7917.pdf.
 MedPAC, 19. Report to the Congress, March 2009, p. 291.
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 Laura Summer 20. et al., “Low-Income Subsidy Plan Availability,” Kaiser Family 
Foundation, November 2008; available at www.kff.org/medicare/upload/7836.pdf.
 MedPAC, 21. Report to the Congress, March 2009, p. 277. 
 This example is for illustrative purposes only; the actual calculation is more 22. 
complex. 
 See, for example, work conducted for MedPAC by Dr. John Hsu, transcript from 23. 
MedPAC Public Meeting, October 2, 2008, pp. 7–21; available at www.medpac.gov/
transcripts/1002-1003medPac.pdf.
 The regulation (CMS-4133-CN) making this change can be found at  24. 
www.cms.hhs.gov/PrescriptionDrugcovcontra/Downloads/cmS4133c.pdf.
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aPPEnDIx 1 (nex t page) :
low- Income Premium Subsidy amounts and number of 
Plans at or Below Benchmark, 2006 –2009
There is a fair amount of variation in the low-income benchmark 
premiums nationwide. For 2009, regional low-income benchmark 
premiums ranged from a low of $16.22 in Arizona to a high of $38.15 
in Wisconsin. There is also much variation in the number of drug 
plans with premiums at or below the low-income benchmark pre-
mium in a region. For example, in 2009, Wisconsin beneficiaries may 
choose among 16 plans below the benchmark, whereas Nevada ben-
eficiaries only have 1 plan with premiums below the benchmark. 
Most regions have between 8 and 12 zero-premium plans. 
Sources: Centers for Medicare & Medicaid Services, 2009 Landscape Source and 2008 Land-
scape Source, www.cms.hhs.gov/PrescriptionDrugcovGenIn. 2007 and 2006 Landscape Source files 
no longer available online; accessed April 2009. And "Medicare Part D, Prescription Drug Plan 
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aPPEnDIx 1
rEgiON / STATE 2006 ($) PLANS 2007 ($) PLANS 2008 ($) PLANS 2009 ($) PLANS
1 NH, ME 36.09 14 30.72 21 30.64 18 28.12 5
2 CT, MA, ri 30.27 11 27.35 20 29.17 14 31.74 12
3 NY 29.83 15 24.45 16 24.18 15 27.71 9
4 NJ 31.37 14 28.12 20 31.23 18 30.99 7
5 DE, DC, MD 33.46 15 29.65 21 30.78 18 30.85 11
6 PA, WV 32.59 15 28.45 26 26.59 18 29.23 9
7 VA 34.42 16 30.52 21 31.03 17 31.72 13
8 NC 36.30 13 32.13 21 33.43 17 33.45 11
9 SC 34.88 16 31.41 26 31.12 20 32.01 15
10 gA 33.15 14 31.07 21 30.04 18 29.16 11
11 FL 29.07 6 22.63 10 19.16 8 21.47 5
12 AL, TN 32.33 9 29.60 17 28.29 15 29.80 12
13 Mi 33.22 14 30.79 26 30.49 17 32.08 11
14 OH 30.69 10 28.51 22 26.82 15 28.40 6
15 iN, KY 35.69 13 32.42 19 33.50 17 33.95 12
16 Wi 31.27 14 29.67 21 31.03 16 38.15 16
17 iL 31.60 15 29.66 23 30.26 19 30.18 12
18 MO 31.37 10 27.88 15 26.71 13 31.89 6
19 Ar 35.45 13 30.51 23 27.69 18 26.89 12
20 MS 36.39 12 31.70 21 31.35 15 31.53 13
21 LA 34.14 11 28.45 12 24.62 10 27.48 7
22 TX 31.68 16 26.93 19 25.01 15 25.36 14
23 OK 35.13 12 30.35 20 28.04 13 29.36 8
24 KS 33.44 11 30.56 20 30.62 17 33.66 10
25 iA, MN, MT 33.11 14 29.50 20 30.61 16 33.19 9
26 NM 25.95 8 22.72 14 19.28 11 20.55 7
27 CO 28.92 10 27.37 19 24.59 12 30.17 8
28 AZ 24.62 6 21.37 10 15.92 7 16.22 2
29 NV 23.46 7 20.56 9 16.64 5 20.20 1
30 Or, WA 30.60 15 28.71 20 30.19 15 31.76 7
31 iD, uT 33.62 14 31.77 20 33.53 14 37.46 9
32 CA 23.25 10 21.03 14 19.80 9 24.86 6
33 Hi 27.44 8 26.35 18 24.32 10 25.01 5
34 AK 34.66 8 33.56 15 36.42 15 36.00 7
TOTAL PLANS* 2006 Plans 409 2007 Plans 640 2008 Plans 495 2009 Plans 308
*  Includes de minimus plans for 2007 and 2008.
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aPPEnDIx 2
how the low- Income Benchmark Premium  
af fec ts Options for Beneficiaries :  a Multi -year Example
This example illustrates the low-income benchmark calculation for the third, fourth and 
fifth year of the drug benefit in a fictional region. There are 14 PDPs and 3 MA-PDs with 
a range of premiums, and the low-income benchmark is $30.23. Low-income beneficiaries 
qualifying for a zero-premium plan in this region have a choice of four PDPs and three 
MA-PDs. A fifth PDP, whose premium is $31.00, will be permitted to offer their plan to 
LIS beneficiaries for $30.23, 
since the premium is a de 
minimus amount—less than 
$1.00—above the bench-
mark. In future years, the 
de minimus rule will not ap-
ply, similar to what actual-
ly occurred under Part D. 
YEAr 3













 17 PDP 64.00 1 .64
 16 PDP 62.00 2 1.24
 15 PDP 53.00 2 1.06
 14 PDP 47.00 8 3.76
 13 PDP 46.00 6 2.76
 12 PDP 43.00 5 2.15
 11 PDP 42.00 7 2.94
 10 PDP 38.00 6 2.28
   9 PDP 36.00 3 1.08
   8 PDP* 31.00 4 1.24
   7 PDP 30.00 9 2.70
   6 PDP 26.00 8 2.08
   5 PDP 24.00 12 2.88
   4 PDP 18.00 19 3.42
3 ma-PD .00 2 .00
2 ma-PD .00 2 .00
1 ma-PD .00 6 .00





*  PDP 8 qualifies as a de minimus plan 
in year 3 (see above).
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In year 4 of this multi-year example, depicted below, several pieces of the puzzle 
change, quite similar to what actually occurred under Part D. First, plan premiums 
increase. Second, the calculation of the benchmark premium changes, as it did un-
der Part D for 2009. Rather than using enrollment of all beneficiaries, the new cal-
culation only includes the percentage of low-income beneficiaries enrolled in each 
of the plans. In addition, the de minimus policy is no longer in effect. PDP 4, which 
had been the lowest premium plan with the largest market share, increases its pre-
mium to $38.00. Perhaps PDP 4’s cost experience warrants the increase, or perhaps 
the plan does not bid as competitively as possible. The result is that PDP 4 now has 
a premium above the low-income benchmark of $28.07. There are now two PDPs 
and three MA-PDs with premiums below the benchmark. PDP 4—the most popu-
lar plan—and PDP 7 and PDP 8 
are now no longer available to 
low-income beneficiaries at zero 
premium. Low-income beneficia-
ries qualifying for zero premium 
may stay in the plan and pay the 
additional premium, select and 
enroll in another plan, or be au-
tomatically enrolled in another 
plan by Medicare.
YEAr 4













17 PDP 68.00 0 .00
16 PDP 67.00 0 .00
15 PDP 57.00 0 .00
14 PDP 52.00 0 .00
13 PDP 57.00 0 .00
12 PDP 50.00 0 .00
11 PDP 46.00 0 .00
10 PDP 46.00 0 .00
9 PDP 41.00 0 .00
4 PDP 38.00 29  11.02
8 PDP 35.00 0  .00
7 PDP 32.00 20  6.40
5 PDP 24.00 24  5.76
6 PDP 23.00 21  4.83
3 ma-PD .00 2  .00
2 ma-PD .00 3  .00
1 ma-PD 6.00 1  .06
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In year 5, three MA-PDs now have premiums, perhaps because Medicare managed care payments de-
creased and plans decide to increase or add a premium for prescription drug coverage. Premiums have 
increased across the board, as one would expect. In addition, PDP 4 has lost considerable market share, 
and drops its premium. The overall result is a shift in the benchmark premium to $25.88, with one PDP 
and three MA-PDs having pre-
miums below the benchmark, 
somewhat similar to the real-
world experience of Nevada in 
2009. Notice that PDP 4 is back 
under the benchmark, so it is 
available to low-income benefi-
ciaries for zero premium. Some 
of the beneficiaries who were en-
rolled in PDP 4 in year 3, disen-
rolled for year 4, are once again 
in PDP 4 for year 5.
YEAr 5













17 PDP 70.00 0  .00
16 PDP 69.00 0 .00
15 PDP 59.00 0 .00
14 PDP 54.00 0 .00
13 PDP 61.00 0 .00
12 PDP 52.00 0 .00
11 PDP 52.00 0 .00
10 PDP 48.00 0 .00
9 PDP 43.00 0 .00
8 PDP 37.00 0 .00
7 PDP 34.00 3  1.02
6 PDP 26.00 45  11.70
5 PDP 26.00 46  11.96
4 PDP 25.00 3  .75
3 ma-PD 18.00 1  .18
2 ma-PD 15.00 1  .15
1 ma-PD 12.00 1  .12











In this simplified multi-year example, the low-income benchmark premium has declined, and with it the number 
of options available to most low-income beneficiaries for zero premium. While reality may differ from this exam-
ple for many beneficiaries, for others it mirrors their experience under Part D. Plan premium amounts, plan enroll-
ment, including MA-PDs in the calculation, plan willingness to attract low-income beneficiaries, and plan payment 
(including risk adjustment) all play a role in determining which plans have premiums below the benchmark.
